Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review.
BMC Anesthesiol
; 22(1): 385, 2022 Dec 12.
Article
in English
| MEDLINE | ID: covidwho-2162294
ABSTRACT
BACKGROUND:
Primary viral myocarditis associated with severe acute respiratory syndrome coronavirus 2 (SARS-Cov2) infection is a rare diagnosis. CASE PRESENTATION We report the case of an unvaccinated, healthy patient with cardiogenic shock in the context of a COVID-19-associated myocarditis and therapy with simultaneous veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and percutaneous left ventricular decompression therapy with an Impella. The aim of this review is to provide an overview of therapeutic options for patients with COVID-19-associated myocarditis.CONCLUSIONS:
The majority of patients required a combination of two assist devices to achieve sufficient cardiac output until recovery of left ventricular ejection fraction. Due to the rapid onset of this fulminant cardiogenic shock immediate invasive bridging therapy in a specialized center was lifesaving.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Heart-Assist Devices
/
COVID-19
/
Myocarditis
Type of study:
Case report
/
Diagnostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
BMC Anesthesiol
Year:
2022
Document Type:
Article
Affiliation country:
S12871-022-01890-4
Similar
MEDLINE
...
LILACS
LIS